Novacyt S.A. (CDI)

NCYT · AIM · Health Care · mcap £29m · 40.4p

Beta Briefing, track record and bull & bear case are not ready for Novacyt S.A. (CDI) yet.

We follow 817 UK small caps and every one of their announcements – often hundreds per company. 61 companies are already wired into a briefing: browse them.

Directors

purchase Novacyt S.A. announced that its CEO, Lyn Rees, purchased 73,379 ordinary shares at an average price of €0.3899, Chairman John Brown acquired 73,762 ordinary shares at an average price of €0.3899, and Non-Executive Direct 30 Mar 2026

other Novacyt S.A. announced that Dr. Joanne Mason is stepping down as Chief Scientific Officer and a member of the Board of Directors, effective immediately, to pursue other business ventures. The company expressed gratitude 7 May 2026

Company filings. Not investment advice.